{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:51:18Z","timestamp":1791172278207,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["Ref. No. 221610161839"],"award-info":[{"award-number":["Ref. No. 221610161839"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020571","name":"Berhampur University","doi-asserted-by":"publisher","award":["264\/R&DC\/BU\/24"],"award-info":[{"award-number":["264\/R&DC\/BU\/24"]}],"id":[{"id":"10.13039\/501100020571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020571","name":"Berhampur University","doi-asserted-by":"publisher","award":["3445\/R&DC\/BU\/25"],"award-info":[{"award-number":["3445\/R&DC\/BU\/25"]}],"id":[{"id":"10.13039\/501100020571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Phys"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10867-026-09728-7","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:58:30Z","timestamp":1791169110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated computational approaches for identifying and evaluating phytochemical inhibitors against HCV NS3\/4A protease"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7919-3492","authenticated-orcid":false,"given":"Sourabha","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5727-165X","authenticated-orcid":false,"given":"Jarmani","family":"Dansana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7575-785X","authenticated-orcid":false,"given":"Abhishikta","family":"Gadtya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4131-7000","authenticated-orcid":false,"given":"Vishma","family":"Mallik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0519-9074","authenticated-orcid":false,"given":"Biswa Ranjan","family":"Meher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"9728_CR1","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","volume":"62","author":"J-M Pawlotsky","year":"2015","unstructured":"Pawlotsky, J.-M., Feld, J.J., Zeuzem, S., Hoofnagle, J.H.: From non-A, non-B hepatitis to hepatitis C virus cure. J. Hepatol. 62, S87\u2013S99 (2015). https:\/\/doi.org\/10.1016\/j.jhep.2015.02.006","journal-title":"J. Hepatol."},{"key":"9728_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1743-422X-9-57","volume":"9","author":"W Aman","year":"2012","unstructured":"Aman, W., Mousa, S., Shiha, G., Mousa, S.A.: Current status and future directions in the management of chronic hepatitis C. Virol. J. 9, 57 (2012). https:\/\/doi.org\/10.1186\/1743-422X-9-57","journal-title":"Virol. J."},{"key":"9728_CR3","doi-asserted-by":"publisher","first-page":"734","DOI":"10.20452\/pamw.542","volume":"118","author":"J Czepiel","year":"2008","unstructured":"Czepiel, J., Biesiada, G., Mach, T.: Viral hepatitis C. Pol. Arch. Med. Wewn. 118, 734\u2013740 (2008)","journal-title":"Pol. Arch. Med. Wewn."},{"key":"9728_CR4","unstructured":"World Health Organization. Hepatitis C. World Health Organization. (2024). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"9728_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1053\/j.gastro.2018.10.024","volume":"156","author":"TF Baumert","year":"2019","unstructured":"Baumert, T.F., Berg, T., Lim, J.K., Nelson, D.R.: Status of Direct-acting antiviral therapy for HCV infection and remaining challenges. Gastroenterology 156, 431\u2013445 (2019). https:\/\/doi.org\/10.1053\/j.gastro.2018.10.024","journal-title":"Gastroenterology"},{"key":"9728_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/apt.14977","volume":"48","author":"BL Pearlman","year":"2018","unstructured":"Pearlman, B.L., Hinds, A.E.: Review article: novel antivirals for hepatitis C-sofosbuvir\/velpatasvir\/voxilaprevir, glecaprevir\/pibrentasvir. Aliment. Pharmacol. Ther. 48, 914\u2013923 (2018). https:\/\/doi.org\/10.1111\/apt.14977","journal-title":"Aliment. Pharmacol. Ther."},{"key":"9728_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40265-018-0895-5","volume":"78","author":"Y-A Heo","year":"2018","unstructured":"Heo, Y.-A., Deeks, E.D.: Sofosbuvir\/velpatasvir\/voxilaprevir: a review in chronic hepatitis C. Drugs 78, 577\u2013587 (2018). https:\/\/doi.org\/10.1007\/s40265-018-0895-5","journal-title":"Drugs"},{"key":"9728_CR8","doi-asserted-by":"publisher","unstructured":"Zeuzem, S., et al.: Glecaprevir\u2013Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection | New England J. Med. https:\/\/doi.org\/10.1056\/NEJMoa1702417","DOI":"10.1056\/NEJMoa1702417"},{"key":"9728_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","volume":"61","author":"JP Messina","year":"2015","unstructured":"Messina, J.P., Humphreys, I., Flaxman, A., Brown, A., Cooke, G.S., Pybus, O.G., Barnes, E.: Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61, 77\u201387 (2015). https:\/\/doi.org\/10.1002\/hep.27259","journal-title":"Hepatology"},{"key":"9728_CR10","doi-asserted-by":"publisher","first-page":"a036947","DOI":"10.1101\/cshperspect.a036947","volume":"10","author":"AL Cox","year":"2020","unstructured":"Cox, A.L.: Challenges and promise of a hepatitis C virus vaccine. Cold Spring Harb. Perspect. Med. 10, a036947 (2020). https:\/\/doi.org\/10.1101\/cshperspect.a036947","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"9728_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.meegid.2011.01.017","volume":"11","author":"S Khaliq","year":"2011","unstructured":"Khaliq, S., Jahan, S., Pervaiz, A.: Sequence variability of HCV core region: important predictors of HCV induced pathogenesis and viral production. Infect. Genet. Evol. 11, 543\u2013556 (2011). https:\/\/doi.org\/10.1016\/j.meegid.2011.01.017","journal-title":"Infect. Genet. Evol."},{"key":"9728_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","author":"S Blach","year":"2017","unstructured":"The Polaris Observatory HCV Collaborators, Blach, S., Zeuzem, S., Manns, M., Altraif, I., Duberg, A.S., Muljono, D.H., Waked, I., Alavian, S.M., Lee, M.H., Negro, F., Abaalkhail, F., Abdou, A., Abdulla, M., Abou Rached, A., Aho, I., Akarca, U., Al Ghazzawi, I., Al Kaabi, S., Al Lawati, F., Al Namaani, K., Al Serkal, Y., Al-Busafi, S.A., Al-Dabal, L., Aleman, S., Alghamdi, A.S., Aljumah, A.A., Al-Romaihi, H.E., Andersson, M.I., Arendt, V., Arkkila, P., Assiri, A.M., Baatarkhuu, O., Bane, A., Ben-Ari, Z., Bergin, C., Bessone, F., Bihl, F., Bizri, A.R., Blachier, M., Blasco, A.J., Brandao Mello, C.E., Bruggmann, P., Brunton, C.R., Calinas, F., Chan, H.L.Y., Chaudhry, A., Cheinquer, H., Chen, C.J., Chien, R.N., Roberts, L.R.: Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol. Hepatol. 2, 161\u2013176 (2017). https:\/\/doi.org\/10.1016\/S2468-1253(16)30181-9","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"9728_CR13","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"E Gower","year":"2014","unstructured":"Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., Razavi, H.: Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 61, S45-57 (2014). https:\/\/doi.org\/10.1016\/j.jhep.2014.07.027","journal-title":"J. Hepatol."},{"key":"9728_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tim.2010.11.005","volume":"19","author":"R Bartenschlager","year":"2011","unstructured":"Bartenschlager, R., Penin, F., Lohmann, V., Andr\u00e9, P.: Assembly of infectious hepatitis C virus particles. Trends Microbiol. 19, 95\u2013103 (2011). https:\/\/doi.org\/10.1016\/j.tim.2010.11.005","journal-title":"Trends Microbiol."},{"key":"9728_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/B978-1-4377-0881-3.00007-3","volume-title":"Zakim and Boyer\u2019s Hepatology (Sixth Edition)","author":"D Moradpour","year":"2012","unstructured":"Moradpour, D., Penin, F., Rice, C.: Chapter 7 - replication of hepatitis C virus. In: Boyer, T.D., Manns, M.P., Sanyal, A.J. (eds.) Zakim and Boyer\u2019s Hepatology (Sixth Edition), pp. 97\u2013110. W.B. Saunders, Saint Louis (2012)"},{"key":"9728_CR16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm.3248","volume":"19","author":"TKH Scheel","year":"2013","unstructured":"Scheel, T.K.H., Rice, C.M.: Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat. Med. 19, 837\u2013849 (2013). https:\/\/doi.org\/10.1038\/nm.3248","journal-title":"Nat. Med."},{"key":"9728_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrmicro3098","volume":"11","author":"BD Lindenbach","year":"2013","unstructured":"Lindenbach, B.D., Rice, C.M.: The ins and outs of hepatitis C virus entry and assembly. Nat. Rev. Microbiol. 11, 688\u2013700 (2013). https:\/\/doi.org\/10.1038\/nrmicro3098","journal-title":"Nat. Rev. Microbiol."},{"key":"9728_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrmicro1645","volume":"5","author":"D Moradpour","year":"2007","unstructured":"Moradpour, D., Penin, F., Rice, C.M.: Replication of hepatitis C virus. Nat. Rev. Microbiol. 5, 453\u2013463 (2007). https:\/\/doi.org\/10.1038\/nrmicro1645","journal-title":"Nat. Rev. Microbiol."},{"key":"9728_CR19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2174\/13816128113199990008","volume":"20","author":"L Shang","year":"2014","unstructured":"Shang, L., Lin, K., Yin, Z.: Resistance mutations against HCV protease inhibitors and antiviral drug design. Curr. Pharm. Des. 20, 694\u2013703 (2014)","journal-title":"Curr. Pharm. Des."},{"key":"9728_CR20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrmicro3046","volume":"11","author":"R Bartenschlager","year":"2013","unstructured":"Bartenschlager, R., Lohmann, V., Penin, F.: The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. Nat. Rev. Microbiol. 11, 482\u2013496 (2013). https:\/\/doi.org\/10.1038\/nrmicro3046","journal-title":"Nat. Rev. Microbiol."},{"key":"9728_CR21","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.jhep.2016.07.035","volume":"65","author":"J Bukh","year":"2016","unstructured":"Bukh, J.: The history of hepatitis C virus (HCV): basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control. J. Hepatol. 65, S2\u2013S21 (2016). https:\/\/doi.org\/10.1016\/j.jhep.2016.07.035","journal-title":"J. Hepatol."},{"key":"9728_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0092-8674(00)81350-1","volume":"87","author":"RA Love","year":"1996","unstructured":"Love, R.A., Parge, H.E., Wickersham, J.A., Hostomsky, Z., Habuka, N., Moomaw, E.W., Adachi, T., Hostomska, Z.: The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 87, 331\u2013342 (1996). https:\/\/doi.org\/10.1016\/S0092-8674(00)81350-1","journal-title":"Cell"},{"key":"9728_CR23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2174\/13816128113199990008","volume":"20","author":"L Shang","year":"2014","unstructured":"Shang, L., Lin, K., Yin, Z.: Resistance mutations against HCV protease inhibitors and antiviral drug design. Curr. Pharm. Des. 20, 694\u2013703 (2014). https:\/\/doi.org\/10.2174\/13816128113199990008","journal-title":"Curr. Pharm. Des."},{"key":"9728_CR24","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/v16081250","volume":"16","author":"K Iman","year":"2024","unstructured":"Iman, K., Mirza, M.U., Sadia, F., Froeyen, M., Trant, J.F., Chaudhary, S.U.: Pharmacophore-assisted covalent docking identifies a potential covalent inhibitor for drug-resistant genotype 3 variants of hepatitis C viral NS3\/4A serine protease. Viruses 16, 1250 (2024). https:\/\/doi.org\/10.3390\/v16081250","journal-title":"Viruses"},{"key":"9728_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031300","volume":"28","author":"M Riaz","year":"2023","unstructured":"Riaz, M., Rehman, A.U., Waqas, M., Khalid, A., Abdalla, A.N., Mahmood, A., Hu, J., Wadood, A.: A novel approach to develop new and potent inhibitors for the simultaneous inhibition of protease and helicase activities of HCV NS3\/4A protease: a computational approach. Molecules 28, 1300 (2023). https:\/\/doi.org\/10.3390\/molecules28031300","journal-title":"Molecules"},{"key":"9728_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1053\/j.gastro.2016.09.045","volume":"152","author":"P Kwo","year":"2017","unstructured":"Kwo, P., Gane, E.J., Peng, C.-Y., Pearlman, B., Vierling, J.M., Serfaty, L., Buti, M., Shafran, S., Stryszak, P., Lin, L., Gress, J., Black, S., Dutko, F.J., Robertson, M., Wahl, J., Lupinacci, L., Barr, E., Haber, B.: Effectiveness of elbasvir and grazoprevir combination, with or without ribavirin, for treatment-experienced patients with chronic hepatitis C infection. Gastroenterology 152, 164-175.e4 (2017). https:\/\/doi.org\/10.1053\/j.gastro.2016.09.045","journal-title":"Gastroenterology"},{"key":"9728_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.drup.2018.01.004","volume":"37","author":"MC Sorbo","year":"2018","unstructured":"Sorbo, M.C., Cento, V., Di Maio, V.C., Howe, A.Y.M., Garcia, F., Perno, C.F., Ceccherini-Silberstein, F.: Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018. Drug Resist. Updat. 37, 17\u201339 (2018). https:\/\/doi.org\/10.1016\/j.drup.2018.01.004","journal-title":"Drug Resist. Updat."},{"key":"9728_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.lfs.2018.12.004","volume":"217","author":"AA Ezat","year":"2019","unstructured":"Ezat, A.A., Elshemey, W.M.: A comparative study of the efficiency of HCV NS3\/4A protease drugs against different HCV genotypes using in silico approaches. Life Sci. 217, 176\u2013184 (2019). https:\/\/doi.org\/10.1016\/j.lfs.2018.12.004","journal-title":"Life Sci."},{"key":"9728_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.antiviral.2011.11.007","volume":"93","author":"W Xue","year":"2012","unstructured":"Xue, W., Pan, D., Yang, Y., Liu, H., Yao, X.: Molecular modeling study on the resistance mechanism of HCV NS3\/4A serine protease mutants R155K, A156V and D168A to TMC435. Antivir. Res. 93, 126\u2013137 (2012). https:\/\/doi.org\/10.1016\/j.antiviral.2011.11.007","journal-title":"Antivir. Res."},{"key":"9728_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2019.107154","volume":"83","author":"T Boonma","year":"2019","unstructured":"Boonma, T., Nutho, B., Rungrotmongkol, T., Nunthaboot, N.: Understanding of the drug resistance mechanism of hepatitis C virus NS3\/4A to paritaprevir due to D168N\/Y mutations: a molecular dynamics simulation perspective. Comput. Biol. Chem. 83, 107154 (2019). https:\/\/doi.org\/10.1016\/j.compbiolchem.2019.107154","journal-title":"Comput. Biol. Chem."},{"key":"9728_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1080\/08927022.2014.917298","volume":"41","author":"J Fu","year":"2015","unstructured":"Fu, J., Wei, J.: Molecular dynamics study on drug resistance mechanism of HCV NS3\/4A protease inhibitor: BI201335. Mol. Simul. 41, 674\u2013682 (2015). https:\/\/doi.org\/10.1080\/08927022.2014.917298","journal-title":"Mol. Simul."},{"key":"9728_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jmgm.2019.03.006","volume":"89","author":"J Kammarabutr","year":"2019","unstructured":"Kammarabutr, J., Mahalapbutr, P., Nutho, B., Kungwan, N., Rungrotmongkol, T.: Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3\/4A protease: A molecular dynamics simulation. J. Mol. Graph. Model. 89, 122\u2013130 (2019). https:\/\/doi.org\/10.1016\/j.jmgm.2019.03.006","journal-title":"J. Mol. Graph. Model."},{"key":"9728_CR33","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1128\/aac.00308-12","volume":"56","author":"F McPhee","year":"2012","unstructured":"McPhee, F., Friborg, J., Levine, S., Chen, C., Falk, P., Yu, F., Hernandez, D., Lee, M.S., Chaniewski, S., Sheaffer, A.K., Pasquinelli, C.: Resistance analysis of the hepatitis C virus NS3 protease inhibitor asunaprevir. Antimicrob. Agents Chemother. 56, 3670\u20133681 (2012). https:\/\/doi.org\/10.1128\/aac.00308-12","journal-title":"Antimicrob. Agents Chemother."},{"key":"9728_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N.M., Banck, M., James, C.A., Morley, C., Vandermeersch, T., Hutchison, G.R.: Open Babel: An open chemical toolbox. J. Cheminformatics. 3, 33 (2011). https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J. Cheminformatics."},{"key":"9728_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"S Forli","year":"2016","unstructured":"Forli, S., Huey, R., Pique, M.E., Sanner, M.F., Goodsell, D.S., Olson, A.J.: Computational protein\u2013ligand docking and virtual drug screening with the AutoDock suite. Nat. Protoc. 11, 905\u2013919 (2016). https:\/\/doi.org\/10.1038\/nprot.2016.051","journal-title":"Nat. Protoc."},{"key":"9728_CR36","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., Olson, A.J.: AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009). https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J. Comput. Chem."},{"key":"9728_CR37","doi-asserted-by":"publisher","unstructured":"Haque, E., Anjum, J., Bahar, N.B., Chowdhury, J.A., Chowdhury, A.A., Kabir, S., Sikder, M.A.A., Amran, M.S.: In Silico Study of the Cardioactive Constituents of Tinospora crispa. Dhaka Univ. J. Pharm. Sci. 293\u2013306 (2022). https:\/\/doi.org\/10.3329\/dujps.v20i3.59795","DOI":"10.3329\/dujps.v20i3.59795"},{"key":"9728_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O., Zoete, V.: SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017). https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci. Rep."},{"key":"9728_CR39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/cbdd.13445","volume":"93","author":"JD Tyzack","year":"2019","unstructured":"Tyzack, J.D., Kirchmair, J.: Computational methods and tools to predict cytochrome P450 metabolism for drug discovery. Chem. Biol. Drug Des. 93, 377\u2013386 (2019). https:\/\/doi.org\/10.1111\/cbdd.13445","journal-title":"Chem. Biol. Drug Des."},{"key":"9728_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3329\/dujs.v73i1.81287","volume":"73","author":"T Roy","year":"2025","unstructured":"Roy, T., Milon, T.H., Zamee, A.I., Dipa, S.A., Imran, M.I.A.: In silico molecular docking studies and pharmacokinetic property analysis of phytocompounds from Camellia sinensis targeting MCM2 protein as anti-cancer agent. Dhaka Univ. J. Sci. 73, 67\u201376 (2025). https:\/\/doi.org\/10.3329\/dujs.v73i1.81287","journal-title":"Dhaka Univ. J. Sci."},{"key":"9728_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J.: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3\u201326 (2001). https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9728_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose, A.K., Viswanadhan, V.N., Wendoloski, J.J.: A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J. Comb. Chem. 1, 55\u201368 (1999). https:\/\/doi.org\/10.1021\/cc9800071","journal-title":"J. Comb. Chem."},{"key":"9728_CR43","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires, D.E.V., Blundell, T.L., Ascher, D.B.: PkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58, 4066\u20134072 (2015). https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J. Med. Chem."},{"key":"9728_CR44","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1007\/s11172-017-1954-x","volume":"66","author":"DS Druzhilovskiy","year":"2017","unstructured":"Druzhilovskiy, D.S., Rudik, A.V., Filimonov, D.A., Gloriozova, T.A., Lagunin, A.A., Dmitriev, A.V., Pogodin, P.V., Dubovskaya, V.I., Ivanov, S.M., Tarasova, O.A., Bezhentsev, V.M., Murtazalieva, K.A., Semin, M.I., Maiorov, I.S., Gaur, A.S., Sastry, G.N., Poroikov, V.V.: Computational platform Way2Drug: from the prediction of biological activity to drug repurposing. Russ. Chem. Bull. 66, 1832\u20131841 (2017). https:\/\/doi.org\/10.1007\/s11172-017-1954-x","journal-title":"Russ. Chem. Bull."},{"key":"9728_CR45","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s11172-019-2683-0","volume":"68","author":"VV Poroikov","year":"2019","unstructured":"Poroikov, V.V., Filimonov, D.A., Gloriozova, T.A., Lagunin, A.A., Druzhilovskiy, D.S., Rudik, A.V., Stolbov, L.A., Dmitriev, A.V., Tarasova, O.A., Ivanov, S.M., Pogodin, P.V.: Computer-aided prediction of biological activity spectra for organic compounds: the possibilities and limitations. Russ. Chem. Bull. 68, 2143\u20132154 (2019). https:\/\/doi.org\/10.1007\/s11172-019-2683-0","journal-title":"Russ. Chem. Bull."},{"key":"9728_CR46","doi-asserted-by":"crossref","unstructured":"Mulyati, B., Panjaitan, R.S.: Study of molecular docking of alkaloid derivative compounds from stem karamunting (Rhodomyrtus tomentosa) Against \u03b1-Glucosidase Enzymes. (2021)","DOI":"10.30598\/\/ijcr.2020.9-bud"},{"key":"9728_CR47","doi-asserted-by":"publisher","first-page":"2200305","DOI":"10.1002\/ardp.202200305","volume":"356","author":"M Eugui","year":"2023","unstructured":"Eugui, M., Lucero, V., do Carmo, H., Cabrera, M., Moyna, G.: Synthesis and antitumoral evaluation of natural product-like compounds based on tropolone and benzotropolone derivatives. Arch. Pharm. (Weinheim) 356, 2200305 (2023). https:\/\/doi.org\/10.1002\/ardp.202200305","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"9728_CR48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","volume":"50","author":"DA Filimonov","year":"2014","unstructured":"Filimonov, D.A., Lagunin, A.A., Gloriozova, T.A., Rudik, A.V., Druzhilovskii, D.S., Pogodin, P.V., Poroikov, V.V.: Prediction of the biological activity spectra of organic compounds using the Pass online web resource. Chem. Heterocycl. Compd. 50, 444\u2013457 (2014). https:\/\/doi.org\/10.1007\/s10593-014-1496-1","journal-title":"Chem. Heterocycl. Compd."},{"key":"9728_CR49","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bioinformatics\/16.8.747","volume":"16","author":"A Lagunin","year":"2000","unstructured":"Lagunin, A., Stepanchikova, A., Filimonov, D., Poroikov, V.: PASS: prediction of activity spectra for biologically active substances. Bioinformatics 16, 747\u2013748 (2000). https:\/\/doi.org\/10.1093\/bioinformatics\/16.8.747","journal-title":"Bioinformatics"},{"key":"9728_CR50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O., Olson, A.J.: AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010). https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J. Comput. Chem."},{"key":"9728_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ph17020261","volume":"17","author":"O Abchir","year":"2024","unstructured":"Abchir, O., Khedraoui, M., Nour, H., Yamari, I., Errougui, A., Samadi, A., Chtita, S.: Integrative approach for designing novel triazole derivatives as \u03b1-glucosidase inhibitors: QSAR, molecular docking, ADMET, and molecular dynamics investigations. Pharmaceuticals 17, 261 (2024). https:\/\/doi.org\/10.3390\/ph17020261","journal-title":"Pharmaceuticals"},{"key":"9728_CR52","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J.A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K.E., Simmerling, C.: ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015). https:\/\/doi.org\/10.1021\/acs.jctc.5b00255","journal-title":"J. Chem. Theory Comput."},{"key":"9728_CR53","doi-asserted-by":"publisher","unstructured":"D. A. Case, I.Y. Ben-Shalom, S.R. Brozell, D.S. Cerutti, Cheatham, T.E., V.W.D. Cruzeiro, T.A. Darden, R.E. Duke, D. Ghoreishi, M.K. Gilson, H. Gohlke, A.W. Goetz, D. Greene, Harris, R.C., N. Homeyer, Yandong Huang, S. Izadi, A. Kovalenko, T. Kurtzman, T.S. Lee, S. LeGrand, P. Li, C. Lin, J. Liu, T. Luchko, R. Luo, D.J. Mermelstein, K.M. Merz, Y. Miao, G. Monard, C. Nguyen, H. Nguyen, I. Omelyan, A. Onufriev, F. Pan, R. Qi, D.R. Roe, A. Roitberg, C. Sagui, S. Schott-Verdugo, Shen, J., C.L. Simmerling, J. Smith, R. Salomon- Ferrer, J. Swails, R.C. Walker, J. Wang, H. Wei, R.M. Wolf, X. Wu, L. Xiao, D.M. York, P.A. Kollman: Amber 2018, (2018). https:\/\/www.researchgate.net\/doi\/https:\/\/doi.org\/10.13140\/RG.2.2.31525.68321","DOI":"10.13140\/RG.2.2.31525.68321"},{"key":"9728_CR54","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/08927022.2022.2060968","volume":"48","author":"M Panda","year":"2022","unstructured":"Panda, M., Purohit, P., Meher, B.R.: Structure-based virtual screening, ADMET profiling, and molecular dynamics simulation studies on HIV-1 protease for identification of active phytocompounds as potential anti-HIV agents. Mol. Simul. 48, 1031\u20131049 (2022). https:\/\/doi.org\/10.1080\/08927022.2022.2060968","journal-title":"Mol. Simul."},{"key":"9728_CR55","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00894-022-05355-w","volume":"28","author":"P Purohit","year":"2022","unstructured":"Purohit, P., Sahoo, S., Panda, M., Sahoo, P.S., Meher, B.R.: Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies. J. Mol. Model. 28, 365 (2022). https:\/\/doi.org\/10.1007\/s00894-022-05355-w","journal-title":"J. Mol. Model."},{"key":"9728_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jmgm.2014.11.003","volume":"56","author":"BR Meher","year":"2015","unstructured":"Meher, B.R., Wang, Y.: Exploring the drug resistance of V32I and M46L mutant HIV-1 protease to inhibitor TMC114: Flap dynamics and binding mechanism. J. Mol. Graph. Model. 56, 60\u201373 (2015). https:\/\/doi.org\/10.1016\/j.jmgm.2014.11.003","journal-title":"J. Mol. Graph. Model."},{"key":"9728_CR57","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1080\/07391102.2022.2059008","volume":"41","author":"P Purohit","year":"2023","unstructured":"Purohit, P., Dash, J.J., Muya, J.T., Meher, B.R.: Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 Mpro: an in silico approach towards drug repurposing. J. Biomol. Struct. Dyn. 41, 3900\u20133913 (2023). https:\/\/doi.org\/10.1080\/07391102.2022.2059008","journal-title":"J. Biomol. Struct. Dyn."},{"key":"9728_CR58","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe, D.R., Cheatham, T.E.I.: PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 9, 3084\u20133095 (2013). https:\/\/doi.org\/10.1021\/ct400341p","journal-title":"J. Chem. Theory Comput."},{"key":"9728_CR59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/wcms.1121","volume":"3","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer, R., Case, D.A., Walker, R.C.: An overview of the Amber biomolecular simulation package. WIREs Comput. Mol. Sci. 3, 198\u2013210 (2013). https:\/\/doi.org\/10.1002\/wcms.1121","journal-title":"WIREs Comput. Mol. Sci."},{"key":"9728_CR60","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S., Ryde, U.: The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449\u2013461 (2015). https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin. Drug Discov."},{"key":"9728_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53111-2","volume":"14","author":"Z-S Yang","year":"2024","unstructured":"Yang, Z.-S., Li, T.-S., Huang, Y.-S., Chang, C.-C., Chien, C.-M.: Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants. Sci. Rep. 14, 2753 (2024). https:\/\/doi.org\/10.1038\/s41598-024-53111-2","journal-title":"Sci. Rep."},{"key":"9728_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2023.108005","volume":"108","author":"P Purohit","year":"2024","unstructured":"Purohit, P., Barik, D., Dansana, J., Meher, B.R.: Investigating Lycotoxin-An1a (An1a), a defense antiviral peptide from Alopecosa nagpag venom as prospective anti-dengue agent against DENV-2 NS2B-NS3 protease. Comput. Biol. Chem. 108, 108005 (2024). https:\/\/doi.org\/10.1016\/j.compbiolchem.2023.108005","journal-title":"Comput. Biol. Chem."},{"key":"9728_CR63","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jmgm.2011.06.003","volume":"30","author":"J Chen","year":"2011","unstructured":"Chen, J., Wang, J., Xu, B., Zhu, W., Li, G.: Insight into mechanism of small molecule inhibitors of the MDM2\u2013p53 interaction: molecular dynamics simulation and free energy analysis. J. Mol. Graph. Model. 30, 46\u201353 (2011). https:\/\/doi.org\/10.1016\/j.jmgm.2011.06.003","journal-title":"J. Mol. Graph. Model."},{"key":"9728_CR64","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jmgm.2011.07.003","volume":"30","author":"S-Y Lu","year":"2011","unstructured":"Lu, S.-Y., Jiang, Y.-J., Zou, J.-W., Wu, T.-X.: Molecular modeling and molecular dynamics simulation studies on pyrrolopyrimidine-based \u03b1-helix mimetic as dual inhibitors of MDM2 and MDMX. J. Mol. Graph. Model. 30, 167\u2013178 (2011). https:\/\/doi.org\/10.1016\/j.jmgm.2011.07.003","journal-title":"J. Mol. Graph. Model."},{"key":"9728_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26082383","volume":"26","author":"N Forouzesh","year":"2021","unstructured":"Forouzesh, N., Mishra, N.: An effective MM\/GBSA protocol for absolute binding free energy calculations: a case study on SARS-CoV-2 spike protein and the human ACE2 receptor. Molecules 26, 2383 (2021). https:\/\/doi.org\/10.3390\/molecules26082383","journal-title":"Molecules"},{"key":"9728_CR66","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1021\/ci3001919","volume":"52","author":"S Genheden","year":"2012","unstructured":"Genheden, S., Kuhn, O., Mikulskis, P., Hoffmann, D., Ryde, U.: The normal-mode entropy in the MM\/GBSA method: effect of system truncation, buffer region, and dielectric constant. J. Chem. Inf. Model. 52, 2079\u20132088 (2012). https:\/\/doi.org\/10.1021\/ci3001919","journal-title":"J. Chem. Inf. Model."},{"key":"9728_CR67","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1080\/07391102.2023.2212798","volume":"42","author":"P Purohit","year":"2024","unstructured":"Purohit, P., Barik, D., Agasti, S., Panda, M., Meher, B.R.: Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations. J. Biomol. Struct. Dyn. 42, 2990\u20133009 (2024). https:\/\/doi.org\/10.1080\/07391102.2023.2212798","journal-title":"J. Biomol. Struct. Dyn."},{"key":"9728_CR68","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1021\/jm0609162","volume":"50","author":"T Hou","year":"2007","unstructured":"Hou, T., Yu, R.: Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance. J. Med. Chem. 50, 1177\u20131188 (2007). https:\/\/doi.org\/10.1021\/jm0609162","journal-title":"J. Med. Chem."},{"key":"9728_CR69","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1080\/07391102.2020.1751298","volume":"39","author":"SA Khan","year":"2021","unstructured":"Khan, S.A., Zia, K., Ashraf, S., Uddin, R., Ul-Haq, Z.: Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. J. Biomol. Struct. Dyn. 39, 2607\u20132616 (2021). https:\/\/doi.org\/10.1080\/07391102.2020.1751298","journal-title":"J. Biomol. Struct. Dyn."},{"key":"9728_CR70","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1080\/07391102.2020.1777901","volume":"39","author":"NA Murugan","year":"2021","unstructured":"Murugan, N.A., Pandian, C.J., Jeyakanthan, J.: Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials. J. Biomol. Struct. Dyn. 39, 4415\u20134426 (2021). https:\/\/doi.org\/10.1080\/07391102.2020.1777901","journal-title":"J. Biomol. Struct. Dyn."},{"key":"9728_CR71","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/j5020021","volume":"5","author":"A Kitao","year":"2022","unstructured":"Kitao, A.: Principal component analysis and related methods for investigating the dynamics of biological macromolecules. J. 5, 298\u2013317 (2022). https:\/\/doi.org\/10.3390\/j5020021","journal-title":"J."},{"key":"9728_CR72","doi-asserted-by":"publisher","DOI":"10.1063\/1.5049637","volume":"149","author":"F Sittel","year":"2018","unstructured":"Sittel, F., Stock, G.: Perspective: identification of collective variables and metastable states of protein dynamics. J. Chem. Phys. 149, 150901 (2018). https:\/\/doi.org\/10.1063\/1.5049637","journal-title":"J. Chem. Phys."},{"key":"9728_CR73","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski, R.A., Jab\u0142o\u0144ska, J., Pravda, L., Va\u0159ekov\u00e1, R.S., Thornton, J.M.: PDBsum: structural summaries of PDB entries. Protein Sci. 27, 129\u2013134 (2018). https:\/\/doi.org\/10.1002\/pro.3289","journal-title":"Protein Sci."},{"key":"9728_CR74","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1053\/j.gastro.2012.03.036","volume":"143","author":"S Haid","year":"2012","unstructured":"Haid, S., Novodomsk\u00e1, A., Gentzsch, J., Grethe, C., Geuenich, S., Bankwitz, D., Chhatwal, P., Jannack, B., Hennebelle, T., Bailleul, F., Keppler, O.T., Poenisch, M., Bartenschlager, R., Hernandez, C., Lemasson, M., Rosenberg, A.R., Wong-Staal, F., Davioud-Charvet, E., Pietschmann, T.: A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. Gastroenterology 143, 213-222.e5 (2012). https:\/\/doi.org\/10.1053\/j.gastro.2012.03.036","journal-title":"Gastroenterology"},{"key":"9728_CR75","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01620-17","volume":"62","author":"TI Ng","year":"2017","unstructured":"Ng, T.I., Tripathi, R., Reisch, T., Lu, L., Middleton, T., Hopkins, T.A., Pithawalla, R., Irvin, M., Dekhtyar, T., Krishnan, P., Schnell, G., Beyer, J., McDaniel, K.F., Ma, J., Wang, G., Jiang, L.-J., Or, Y.S., Kempf, D., Pilot-Matias, T., Collins, C.: In vitro antiviral activity and resistance profile of the next-generation hepatitis C virus NS3\/4A protease inhibitor glecaprevir. Antimicrob. Agents Chemother. 62, e01620-17 (2017). https:\/\/doi.org\/10.1128\/AAC.01620-17","journal-title":"Antimicrob. Agents Chemother."},{"key":"9728_CR76","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.1074\/jbc.M116.772996","volume":"292","author":"Z Guo","year":"2017","unstructured":"Guo, Z., Black, S., Hu, Y., McMonagle, P., Ingravallo, P., Chase, R., Curry, S., Asante-Appiah, E.: Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3\/4A protease from genotype 1a. J. Biol. Chem. 292, 6202\u20136212 (2017). https:\/\/doi.org\/10.1074\/jbc.M116.772996","journal-title":"J. Biol. Chem."},{"key":"9728_CR77","doi-asserted-by":"publisher","unstructured":"Han, B., Parhy, B., Lu, J., Zhou, E., Hsieh, D., Camus, G., Martin, R., Svarovskaia, E.S., Mo, H., Dvory-Sobol, H.: In vitro susceptibility of hepatitis c virus genotype 1 through 6 clinical isolates to the pangenotypic NS3\/4A inhibitor voxilaprevir. J. Clin. Microbiol. 57, e01844\u201318 (2019). https:\/\/doi.org\/10.1128\/JCM.01844-18","DOI":"10.1128\/JCM.01844-18"}],"container-title":["Journal of Biological Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10867-026-09728-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10867-026-09728-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10867-026-09728-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:58:33Z","timestamp":1791169113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10867-026-09728-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9728"],"URL":"https:\/\/doi.org\/10.1007\/s10867-026-09728-7","relation":{},"ISSN":["0092-0606","1573-0689"],"issn-type":[{"value":"0092-0606","type":"print"},{"value":"1573-0689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"32"}}